surmount studies tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT‐1 study design. This is

PH, pixel heterogeneity

These findings indicate that treatment with semaglutide consistently benefits women with significant weight loss throughout all life stages and that early treatment, before the menopause transition begins, could lead to additional weight loss

If youve already reached the maximum approved dose of 15 mg and weight loss hasnt resumed, your provider may talk with you about switching medications or exploring other approaches

R.FosterW

You can join the waitlist for Retatrutide and complete the consultation form on our website

The injectable forms of semaglutide Ozempic for diabetes and Wegovy for weight loss have solid evidence backing up their claims of cardiovascular protection